Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 494.00
Low: 494.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Disposal – Summa Insurance

11 Jan 2022 07:00

RNS Number : 9987X
B.P. Marsh & Partners PLC
11 January 2022
 

Date: 11 January 2022

 

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Investee Company Disposal - Summa Insurance Brokerage, S.L.

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist investor in early-stage financial services businesses, is pleased to announce the conditional disposal of its entire 77.25% shareholding in Summa Insurance Brokerage, S.L. ("Summa"), the Madrid based Spanish insurance broker consolidator, to Acrisure España S.L., part of Acrisure LLC, the global financial services business.

 

This sale is conditional upon, inter alia, the approval of the Direccion General de Seguros, the Spanish financial regulator, that supervises and controls Spain's insurance sector.

 

Upon completion, the Group will receive cash consideration of €9,715,484 (£8,113,817), after all associated costs, for its 77.25% shareholding in Summa. As at 31 July 2021, the most recent published valuation, the Group valued its shareholding in Summa at £7,984,000.

 

As such, the proposed sale represents an uplift of £129,817 over this most recent valuation.

 

Additionally, upon completion, Acrisure España S.L. will acquire in full the Group's outstanding loan of €1,820,070 (£1,520,018) pursuant to the terms of the disposal, which the Group will receive in cash.

 

For the purposes of this announcement, all figures have been converted at an exchange rate of €1.1974:£1.

 

The Group assisted Summa's management team in the formation of Summa in 2005. During this time, Summa has grown its Revenues to over €11.5m, with offices and franchises throughout Spain.

 

Oliver Bogue, the Company's nominee director on the Board of Summa, will resign from this role on completion of the disposal.

 

Commenting on this disposal, the Group's Chief Investment Officer, Dan Topping stated:-

 

"It has been a pleasure to work with Jose Antonio Vargas Gonzalez, Begoña Larrea Quintana and the whole team at Summa since our original investment back in 2005.

 

"The acquisition by Acrisure will allow Summa to move into its next phase of growth and we wish everyone at Summa all the best for the future.

 

"The sale of our stake in Summa at this valuation is a testament to Summa's Management Team, considering the effects that the 2008 global financial crisis and now the Covid-19 Pandemic have had on the Spanish economy."

 

Jose Antonio Vargas Gonzalez, Summa's President and CEO, commented:-

 

"Following over a decade as our partners in Summa, I would like to thank the B.P. Marsh team for their longstanding support. Whilst Summa have now secured a new partner in Acrisure, B.P. Marsh have been invaluable to getting the business to its current position, for which I am very grateful."

 

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock Communications

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Several of the directors have worked with each other in previous roles, and all have worked with each other for over ten years.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFFFLTIILIF
Date   Source Headline
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.